Basic info
Industry
biotechnology research
Sectors
rare diseases
Biotechnology
inherited retinal disorders
biotechnology
Health Care
therapeutics biologics
ophthalmology
biopharmaceutical
Biopharma
wet AMD
Date founded
2013
Funding rounds raised
Total raised
$100M
from 3 investors over 3 rounds
O
Ocugen raised $100M on April 23, 2021
Investors: ROTH Capital Partners
O
Ocugen raised $7.5M on June 15, 2017
Investors: Lancaster Group Inc and Abdi İbrahim Pharmaceuticals